July 19 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS ANNOUNCES EXPANSION OF MARKET OPPORTUNITY FOR ITS LONG ACTING ANTI-NAUSEA TRANSDERMAL PATCH
* AEQUUS - PLANS TO LAUNCH AQS1303 IN COUNTRIES WHERE ORIGINAL ORAL FORM APPROVED, ACCELERATED PATH TO APPROVAL MAY EXIST FOR REFORMULATED PRODUCTS
* AEQUUS PHARMACEUTICALS - FOLLOWING REVIEW BY MHRA & COMMISSION ON CHM IN JUNE 2018, XONVEA EXPECTED TO BE AVAILABLE IN UK LATER IN 2018